Literature DB >> 1393278

Pharmacological evidence for distinct endothelin receptors in guinea-pig bronchus and aorta.

D W Hay1.   

Abstract

The ETA receptor antagonist, BQ-123 (1 microM) potently antagonized endothelin-1 (ET-1) concentration-response curves in guinea-pig aorta (pKB = 7.1). However, 10 microM BQ-123 was without effect on ET-1-induced contractions in guinea-pig bronchus. The ETB-selective agonist, sarafotoxin S6c did not contract the aorta but was a potent and effective contractile agonist in the bronchus. BQ-123 (10 microM) was without effect on sarafotoxin S6c-induced contractions in the bronchus. These data provide evidence for distinct endothelin receptors in guinea-pig aorta and bronchus, which appear to be predominantly of the ETA and non-ETA, perhaps ETB, subtypes, respectively.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1393278      PMCID: PMC1907674          DOI: 10.1111/j.1476-5381.1992.tb14407.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor.

Authors:  M Ihara; K Noguchi; T Saeki; T Fukuroda; S Tsuchida; S Kimura; T Fukami; K Ishikawa; M Nishikibe; M Yano
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

Review 2.  Endothelin, a novel endothelium-derived peptide. Pharmacological activities, regulation and possible roles in cardiovascular control.

Authors:  M Yanagisawa; T Masaki
Journal:  Biochem Pharmacol       Date:  1989-06-15       Impact factor: 5.858

3.  Cloning and functional expression of human cDNA for the ETB endothelin receptor.

Authors:  A Sakamoto; M Yanagisawa; T Sakurai; Y Takuwa; H Yanagisawa; T Masaki
Journal:  Biochem Biophys Res Commun       Date:  1991-07-31       Impact factor: 3.575

4.  Cloning and expression of a cDNA encoding an endothelin receptor.

Authors:  H Arai; S Hori; I Aramori; H Ohkubo; S Nakanishi
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

5.  Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor.

Authors:  T Sakurai; M Yanagisawa; Y Takuwa; H Miyazaki; S Kimura; K Goto; T Masaki
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

6.  Two different forms of endothelin receptors in rat lung.

Authors:  Y Masuda; H Miyazaki; M Kondoh; H Watanabe; M Yanagisawa; T Masaki; K Murakami
Journal:  FEBS Lett       Date:  1989-11-06       Impact factor: 4.124

7.  The C-terminal hexapeptide, endothelin-(16-21), discriminates between different endothelin receptors.

Authors:  C A Maggi; S Giuliani; R Patacchini; P Santicioli; P Rovero; A Giachetti; A Meli
Journal:  Eur J Pharmacol       Date:  1989-07-04       Impact factor: 4.432

8.  Heterogeneity of endothelin-sarafotoxin receptors mediating contraction of pig coronary artery.

Authors:  V J Harrison; A Randriantsoa; P Schoeffter
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

9.  Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes.

Authors:  D L Williams; K L Jones; D J Pettibone; E V Lis; B V Clineschmidt
Journal:  Biochem Biophys Res Commun       Date:  1991-03-15       Impact factor: 3.575

10.  Evidence for multiple endothelin receptors in the guinea-pig pulmonary artery and trachea.

Authors:  L O Cardell; R Uddman; L Edvinsson
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

  10 in total
  16 in total

1.  Endothelins-induce cyclicAMP formation in the guinea-pig trachea through an ETA receptor- and cyclooxygenase-dependent mechanism.

Authors:  A M el-Mowafy; G A Abou-Mohamed
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

2.  Endothelin receptor subtypes in human and guinea-pig pulmonary tissues.

Authors:  D W Hay; M A Luttmann; W C Hubbard; B J Undem
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

3.  Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.

Authors:  T D Warner; G H Allcock; J R Vane
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

4.  Influence of regional differences in ETA and ETB receptor subtype proportions on endothelin-1-induced contractions in porcine isolated trachea and bronchus.

Authors:  R G Goldie; A C D'Aprile; R Cvetkovski; P J Rigby; P J Henry
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

5.  Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788.

Authors:  K Ishikawa; M Ihara; K Noguchi; T Mase; N Mino; T Saeki; T Fukuroda; T Fukami; S Ozaki; T Nagase
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

6.  Incomplete inhibition of the pressor effects of endothelin-1 and related peptides in the anaesthetized rat with BQ-123 provides evidence for more than one vasoconstrictor receptor.

Authors:  L McMurdo; R Corder; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

7.  Endothelin-1 (ET-1)-induced contraction in rat isolated trachea: involvement of ETA and ETB receptors and multiple signal transduction systems.

Authors:  P J Henry
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

8.  Mediation of endothelin-1-induced inhibition of platelet aggregation via the ETB receptor.

Authors:  L McMurdo; P S Lidbury; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

9.  SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist.

Authors:  E H Ohlstein; P Nambi; S A Douglas; R M Edwards; M Gellai; A Lago; J D Leber; R D Cousins; A Gao; J S Frazee
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

10.  Predominance of endothelinA (ETA) receptors in ovine airway smooth muscle and their mediation of ET-1-induced contraction.

Authors:  R G Goldie; P S Grayson; P G Knott; G J Self; P J Henry
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.